New pill aims to keep narcolepsy patients awake and steady
Symptom relief
Not yet recruiting
This study tests a drug called samelisant in 240 adults with narcolepsy (with or without sudden muscle weakness). The goal is to see if it reduces severe daytime sleepiness and weekly episodes of cataplexy over 12 weeks. Participants will be randomly assigned to receive either sa…
Phase: PHASE3 • Sponsor: Suven Life Sciences Limited • Aim: Symptom relief
Last updated May 15, 2026 11:55 UTC